1-3 of 3
Thomas H. Norwood
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A phase 2 trial of azacitidine and gemtuzumab ozogamicin therapy in older patients with acute myeloid leukemia

Clinical Trials & Observations
Sucha Nand, Megan Othus, John E. Godwin, Cheryl L. Willman, Thomas H. Norwood, Dianna S. Howard, Steven E. Coutre, Harry P. Erba, Frederick R. Appelbaum
Journal: Blood
Blood (2013) 122 (20): 3432–3439.
https://doi.org/10.1182/blood-2013-06-506592
Published: 2013
Journal Articles

Changes in the Pattern of Cytogenetic Aberrations with Advancing Age in Acute Myeloid (Non-APL) Leukemia: A Southwest Oncology Study (S9007).

Thomas H. Norwood, MD, Holly M. Gundacker, MS, Marilyn L. Slovak, PhD, Harry Paul Erba, MD, PhD, Frederick R. Appelbaum, MD
Journal: Blood
Blood (2006) 108 (11): 808.
https://doi.org/10.1182/blood.V108.11.808.808
Published: 2006
Journal Articles

Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group study

Clinical Trials & Observations
Jeanne E. Anderson, Kenneth J. Kopecky, Cheryl L. Willman, David Head, Margaret R. O'Donnell, Frederick W. Luthardt, Thomas H. Norwood, I-Ming Chen, Stanley P. Balcerzak, David B. Johnson, Frederick R. Appelbaum
Journal: Blood
Blood (2002) 100 (12): 3869–3876.
https://doi.org/10.1182/blood-2001-12-0354
Published: 2002